Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints
© 2020, The Author(s). In response to DNA damage, a synthetic lethal relationship exists between the cell cycle checkpoint kinase MK2 and the tumor suppressor p53. Here, we describe the concept of augmented synthetic lethality (ASL): depletion of a third gene product enhances a pre-existing syntheti...
Main Authors: | Kong, Yi Wen, Dreaden, Erik C, Morandell, Sandra, Zhou, Wen, Dhara, Sanjeev S, Sriram, Ganapathy, Lam, Fred C, Patterson, Jesse C, Quadir, Mohiuddin, Dinh, Anh, Shopsowitz, Kevin E, Varmeh, Shohreh, Yilmaz, Ömer H, Lippard, Stephen J, Reinhardt, H Christian, Hemann, Michael T, Hammond, Paula T, Yaffe, Michael B |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2021
|
Online Access: | https://hdl.handle.net/1721.1/133093 |
Similar Items
-
Exploiting synthetic lethal interactions for targeted cancer therapy
by: Reinhardt, H. Christian, et al.
Published: (2012) -
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy
by: Grant, Robert A., et al.
Published: (2016) -
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
by: Pfirschke, Christina, et al.
Published: (2018) -
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
by: Sriram, Ganapathy, et al.
Published: (2023) -
A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
by: Morton, Stephen Winford, et al.
Published: (2014)